Company Ticker News January 12, 2022Moderna (MRNA) Up on Plans to Get Omicron Booster Ready in 2022 0 0 Share
Company Ticker News January 11, 2022Moderna, Inc. (MRNA) CEO Stephane Bancel on JPMorgan 40th Annual Healthcare Conference (Transcript) 0 0 Share
Press Release January 10, 2022Codex DNA Signs Early Access Collaboration and Licensing Agreement with Pfizer to Further Develop Codex DNA's Novel Enzymatic DNA Synthesis Technology for Pfizer's use in its Research and Development of mRNA-based Vaccines and Biotherapies 0 0 Share
Press Release January 10, 2022Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update 0 0 Share
Company Ticker News January 10, 2022A universal flu vaccine may be the next big mRNA breakthrough for Moderna, Pfizer 0 0 Share
Company Ticker News January 7, 2022Moderna (MRNA) Begins Dosing in Study on Vaccine Against EBV 0 0 Share
Company Ticker News January 7, 2022Moderna (MRNA) Gains As Market Dips: What You Should Know 0 0 Share
Press Release January 5, 2022Moderna Announces First Participant Dosed in Phase 1 Study of its mRNA Epstein-Barr Virus (EBV) Vaccine 0 0 Share
Company Ticker News January 1, 2022Moderna (MRNA) Gains As Market Dips: What You Should Know 0 0 Share
Company Ticker News December 24, 2021Moderna (MRNA) Down as Pfizer Paxlovid EUA May Fuel Competition 0 0 Share